
PROMETHEUS PROTOCOL
THEEND OF AGING STARTS WITH YOUR CELLS
SCROLL TO EXPAND
Our MissionPioneering the shift from reactive medicine to proactive healthspan optimization
Celljevity is pioneering the shift from reactive medicine to proactive healthspan optimization, using the best of stem cell science, AI, and elite clinical care.
A world where aging is not inevitable decline, but a treatable condition. Where health is personalized, predictive, and preventive.
Learn MoreCertified Excellence


The Prometheus ProtocolIn Action
Our revolutionary cellular rejuvenation process combines cutting-edge science with proven clinical results, delivering unprecedented age reversal at the cellular level.
Cellular Rejuvenation
Transform aged cells into youthful, vibrant cells through our proprietary Prometheus Protocol.
Telomere Extension
Achieve unprecedented +32% telomere extension, reversing cellular aging markers to new-born stage.
Proprietary Protocol
From initial consultation to cell delivery—our complete rejuvenation process takes approximately 12 weeks.
Multi-System Applications
Comprehensive cellular rejuvenation across skin, joints, cardiovascular, cognitive, immune, and metabolic health.
The Journey to Renewal
The Rejuvenation Process
From collection to results in six precise steps.
Tissue Collection
A small 1cm² skin biopsy is collected from behind the ear under local anesthesia
Cell Isolation
Fibroblasts are isolated and expanded in our GMP-certified laboratories
Rejuvenation Protocol
Proprietary 15-day protocol reverses cellular aging markers
Quality Validation
Single-cell RNA sequencing confirms successful rejuvenation before release
Therapeutic Delivery
20 billion rejuvenated cells delivered via targeted injection or IV infusion
Results & Monitoring
Extended telomeres and rejuvenated cellular markers confirmed through comprehensive testing
Our complete rejuvenation process takes approximately 12 weeks from initial consultation to cell delivery
Learn MoreThe Science Behind Prometheus
Why Epigenetic Reprogramming Works
Aging isn't about worn-out parts—it's about cells that have forgotten how to function. Prometheus Therapy doesn't replace your cells; it updates their operating system.
Based on Dr. Sun's 190+ publications (20,000+ citations) in Nature, Science, and Cell.
Senolytics
Senescent cells accumulate with age, poisoning healthy neighbors. Prometheus Cells identify and eliminate these cellular troublemakers while regenerating tissue.
Epigenetics
DNA methylation patterns control cellular age. Prometheus Therapy resets these patterns—like restoring a vintage car to factory condition without replacing the engine.
Metabolism
Mitochondria lose efficiency with age. Epigenetic reprogramming restores youthful energy production, verified through 32% telomere extension.
Immunology
Aging skews immune responses toward inflammation. Prometheus Cells secrete IL-10 and modulate regulatory T-cells, restoring immune homeostasis.
Global Elite Partner Network
Temples of Transformation
These are not medical offices. They are sanctuaries where science meets soul, where cutting-edge regenerative medicine is delivered in environments designed for total rejuvenation.

Antibes, France
Clinique DelMar
Where luxury meets regenerative medicine on the stunning Côte d'Azur. Our flagship facility combines Mediterranean serenity with cutting-edge cellular therapies, offering the complete Prometheus protocol in an environment designed for healing.
Coming 2026
Global Expansion
Florida, Switzerland, and UAE. Bringing the Celljevity experience to major cities worldwide, each clinic collecting proprietary data to continuously improve our protocols.
The Prometheus Technology
Considerations (Educational Only)
Prometheus protocol is for adults aiming to reverse biological aging, prevent age-related decline, and enhance vitality via cellular rejuvenation.
The following information is educational only. Consult your physician to determine if these treatments may be appropriate for your individual circumstances.
Who Can Benefit from Prometheus Protocol
Our personalized screening process ensures Prometheus therapy is safe and optimal for each candidate, with eligibility criteria designed to maximize therapeutic outcomes.
Criteria & Screening:
Minimum Age: 16
Optimal Age: 40+ with early–moderate age-related decline
Comprehensive Screening: Medical evaluation by care teams
Protocol Considerations:
Adults 40+ with decline in vitality, recovery speed, resilience.
Joint/mobility issues (mild–moderate osteoarthritis, degeneration)
Preventive longevity care
Autoimmune/chronic inflammatory conditions
Biological age reversal (telomere extension)
High-performance individuals (executives, athletes, entrepreneurs)
The research protocol is personalized + eligibility screened.
Learn About EligibilityRequest information about eligibility requirements and treatment considerations. Our team can provide educational resources to help you discuss these options with your healthcare provider.
Latest from Our Blog
Research stories, clinical insights, and platform updates
Explore the latest regenerative discoveries, clinic-ready playbooks, and product launch updates from the Celljevity platform.

Diederik van der Reijt - Celljevity: Pioneering the Future of Cellular Rejuvenation
CEO Diederik van der Reijt discusses Celljevity's vision for revolutionizing healthcare through cellular therapy and the company's ambitious growth plans.

Inclusive Healthcare: Celljevity's Mission to Broaden Access to Advanced Therapies
Celljevity's innovative approach to making advanced cellular therapies accessible to broader populations through strategic partnerships and global expansion.

Breakthrough in Cellular Reprogramming: How Celljevity's Prometheus Therapy Reverses Biological Aging
Revolutionary cellular reprogramming technology shows promising results in reversing biological aging markers and restoring cellular function.
Our Team
World-Class Leadership
Led by experienced executives and guided by distinguished advisors
Leadership Team
Rhys Tombling
Finance Director
London, England
Medical & Scientific Board
Dr. Henry Delmar
Founder, Clinic Del Mar
Nice, France
Dr. Pierre Maldiney
Cardiologist & Anti-Aging Physician
Paris, France
Dr. Lin Quan
Clinical Director, UCLA
Los Angeles, USA
Dr. Murat Bozkurt
Medical Advisor
Ankara, Turkey
Advisory Board
Neil Bush
Senior Advisor
Houston, USA
Rachid Bouzouba
Co-Founder, MCM Partners
Hong Kong
Shirin Azad
Strategic Advisor
Europe
Questions & Answers
Frequently Asked Questions
Everything you need to know about Prometheus therapy
Can't find what you're looking for? Contact our specialist team
Treatment Process
Clinical & Scientific
Still have questions? Contact our specialist team
Contact UsMedical Disclaimer: Celljevity's Prometheus technology is investigational and not FDA-approved. Research protocol options vary by jurisdiction. Individual results may vary. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent disease. Consult your healthcare provider.
